The Vericheck ddPCR Empty-Full Capsid Kits comprise a capsid detection assay in FAM and an ITR-2 assay in HEX. The ITR-2 ...
Watch the recording of the latest AIrTonomy webinar here. » Facility Unveiling – Witness the introduction of a state-of-the-art testing facility designed to advance AAV technology and infrastructure. ...
The US Food and Drug Administration (FDA) has granted clearance to SpliceBio’s investigational new drug (IND) application to ...
From ship to shore to objective, no equipment better defines the distinction and purpose of Marine Corps expeditionary capabilities than the AAV-7 Amphibious Assault Vehicle. Designed to assault ...
Astellas has signed another bolt-on deal to build its gene therapy pipeline, agreeing a deal with Dyno Therapeutics to tap into its adeno-associated virus (AAV) vector platform for delivering ...
Hosted on MSN1mon
Asimov launches AAV Edge, a suite of AI models, host cells, and genetic tools for end-to-end gene therapy developmentProduction system: Today's launch introduces Asimov’s transient transfection-based AAV manufacturing system—the first in a planned series of releases for AAV Edge.This platform features a ...
PackGene recently built, staffed and equipped a dedicated AAV cGMP facility in Houston, Texas that is scheduled to fully launch in early 2024. AAVs have become the therapeutic gene delivery ...
Existing gene therapies have primarily used a small number of naturally occurring AAV vectors limited by low delivery efficiency as well as problems with pre-existing immunity and manufacturability.
The past five years have witnessed United States Food and Drug Administration approval and commercial launch of 20 drug products ... 2 adeno-associated viral (AAV) vector therapies for rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback